pdb_id,structure_name,organism,resolution
5V39,Crystal structure of human vitamin D receptor ligand binding domain in complex with a VDRM,Homo sapiens,2.2
6XZH,Structure of zVDR LBD-Calcitriol in complex with chimera 10,Danio rerio,2.372
6XZI,Structure of zVDR LBD-calcitriol in complex with chimera 11,Danio rerio,2.1
6XZJ,Structure of zVDR LBD-Calcitriol in complex with chimera 12,Danio rerio,2.1
6XZK,Structure of zVDR LBD-Calcitriol in complex with chimera 13,Danio rerio,2.0
6XZV,Structure of zVDR LBD-Calcitriol in complex with chimera 18,Danio rerio,2.3
3B0T,Human VDR ligand binding domain in complex with maxacalcitol,Homo sapiens,1.3
7QPP,High resolution structure of human VDR ligand binding domain in complex with calcitriol,Homo sapiens,1.52
8PWD,Crystal structure of VDR in complex Des-C-Ring and Aromatic-D-Ring analog 3c,Danio rerio,2.8
8PWE,Crystal structure of VDR complex with Novel Des-C-Ring and Aromatic-D-Ring analog 3a,Danio rerio,2.0
8PWF,crystal structure of VDR in complex with Des-C-Ring and Aromatic-D-Ring analog 2,Danio rerio,2.3
8PWM,Crystal structure of VDR in complex with Des-C-Ring and Aromatic-D-Ring analog 3b,Danio rerio,2.3
8PZ6,"crystal structure of VDR in complex with D-Bishomo-1a,25-dihydroxyvitamin D3 analog 56",Danio rerio,2.9
8PZ7,"crystal structure of VDR complex with D-Bishomo-1a,25-dihydroxyvitamin D3 Analog 57",Danio rerio,2.93
8PZ8,"crystal structure of VDR in complex with D-Bishomo-1a,25-dihydroxyvitamin D3 Analog 54",Danio rerio,2.64
8PZ9,"Crystal structure of VDR in complex with D-Bishomo-1a,25-dihydroxyvitamin D3 Analog 55",Danio rerio,2.74
8PZB,"crystal structure of VDR in complex with D-Bishomo-1a,25-dihydroxyvitamin D3 Analog 49",Danio rerio,2.73
9FW8,VDR complex with UG-650,Danio rerio,2.42
1S0Z,Crystal structure of the VDR LBD complexed to seocalcitol.,Homo sapiens,2.5
1S19,Crystal structure of VDR ligand binding domain complexed to calcipotriol.,Homo sapiens,2.1
4IA1,Diastereotopic and Deuterium Effects in Gemini,Danio rerio,2.44
4IA2,Diastereotopic and Deuterium Effects in Gemini,Danio rerio,2.95
4IA3,Diastereotopic and Deuterium Effects in Gemini,Danio rerio,2.7
4IA7,Diastereotopic and Deuterium Effects in Gemini,Danio rerio,2.7
5YSY,"Crystal structure of the human vitamin D receptor ligand binding domain complexed with (1R,2R,3R)-5-[(E)-2-{(1R,3aS,7aR)-1-[(R)-6-hydroxy-6-methylheptan-2-yl]-7a-methyl-2,3,3a,6,7,7a-hexahydro-1H-inden-4-yl}vinyl]-2-(3-hydroxypropyl)cyclohex-4-ene-1,3-diol",Homo sapiens,2.0
5YT2,"Crystal structure of the human vitamin D receptor ligand binding domain complexed with (1R,2S,3R)-5-[(E)-2-{(1R,3aS,7aR)-1-[(R)-6-hydroxy-6-methylheptan-2-yl]-7a-methyl-2,3,3a,6,7,7a-hexahydro-1H-inden-4-yl}vinyl]-2-(3-hydroxypropyl)cyclohex-4-ene-1,3-diol",Homo sapiens,2.0
9EZ1,"Vitamin D receptor in complex with 1,4a,25-trihydroxyvitamin D3",Danio rerio,1.95
9EZ2,"Vitamin D receptor complex with 1,4b,25-trihydroxyvitamin D3",Danio rerio,1.8
9GY8,Vitamin D Receptor complex with Sila-A,Danio rerio,2.2
9GYA,Vitamin D Receptor in complex with Sila-e,Danio rerio,1.85
9GYC,Vitamin D receptor in complex with Sila-d,Danio rerio,2.2
9GYJ,Vitamin D receptor in complex with Sila-c,Danio rerio,1.9
9GYK,Vitamin D receptor in complex with Sila-f,Danio rerio,2.2
6T2M,VDR-ZK168281 complex,Danio rerio,3.0
7OXZ,VDR complex with a side-chain hydroxylated derivative of lithocholic acid,Danio rerio,2.2
7OY4,VDR complex of a side-chain hydroxylated derivatives of lithocholic acid,Danio rerio,2.0
3CS4,Structure-based design of a superagonist ligand for the vitamin D nuclear receptor,Homo sapiens,2.0
3CS6,Structure-based design of a superagonist ligand for the vitamin D nuclear receptor,Homo sapiens,1.8
3M7R,Crystal structure of VDR H305Q mutant,Homo sapiens,1.8
4G2I,Structural basis for the accommodation of bis- and tris-aromatic derivatives in Vitamin D Nuclear Receptor,Homo sapiens,1.8
5GT4,"Crystal structure of the human vitamin D receptor ligand binding domain complexed with (1R,2S,3R,5Z,7E,14beta,17alpha)-2-cyanopropoxy-9,10-secocholesta-5,7,10-triene-1,3,25-triol",Homo sapiens,1.83
8IQN,"Crystal structure of the human vitamin D receptor ligand binding domain complexed with 24,24-F2-25(OH)D3",Homo sapiens,1.639
8IQT,Crystal structure of the human vitamin D receptor ligand binding domain complexed with (23R)-F-25(OH)D3,Homo sapiens,1.745
5XPL,"Crystal structure of VDR-LBD complexed with 22S-butyl-25-hydroxyphenyl-2-methylidene-19,26,27-trinor-25-oxo-1-hydroxyvitamin D3",Rattus norvegicus,2.05
1TXI,Crystal structure of the vdr ligand binding domain complexed to TX522,Homo sapiens,1.9
2HAM,Crystal structure of VDR LBD complexed to 2alpha-propyl-calcitriol,Homo sapiens,1.9
2HAR,Crystal structure of VDR LBD in complex with 2 alpha-(3-hydroxy-1-propoxy) calcitriol,Homo sapiens,1.9
2HAS,Crystal structure of VDR LBD in complex with 2alpha-(1-propoxy) calcitriol,Homo sapiens,1.96
2HB7,Crystal structure of VDR LBD in complex with 2alpha(3-hydroxy-1-propyl) calcitriol,Homo sapiens,1.8
2HB8,Crystal structure of VDR LBD in complex with 2alpha-methyl calcitriol,Homo sapiens,2.0
3A2I,Crystal structure of the human vitamin D receptor (H305F) ligand binding domain complexed with TEI-9647,Homo sapiens,3.27
3A2J,Crystal structure of the human vitamin D receptor (H305F/H397F) ligand binding domain complexed with TEI-9647,Homo sapiens,2.7
3AUQ,Crystal structure of the human vitamin D receptor ligand binding domain complexed with Yne-diene type analog of active 14-epi-2alpha-methyl-19-norvitamin D3,Homo sapiens,2.64
3AUR,Crystal structure of the human vitamin D receptor ligand binding domain complexed with Yne-diene type analog of active 14-epi-2beta-methyl-19-norvitamin D3,Homo sapiens,2.21
3AX8,"Crystal structure of the human vitamin D receptor ligand binding domain complexed with 15alpha-methoxy-1alpha,25-dihydroxyvitamin D3",Homo sapiens,2.6
3AZ1,Crystal Structure Analysis of Vitamin D receptor,Homo sapiens,1.5
3AZ2,Crystal Structure Analysis of Vitamin D receptor,Homo sapiens,1.69
3AZ3,Crystal Structure Analysis of Vitamin D receptor,Homo sapiens,1.36
3O1D,"Structure-function study of Gemini derivatives with two different side chains at C-20, Gemini-0072 and Gemini-0097.",Danio rerio,2.4007
3O1E,"Structure-function of Gemini derivatives with two different side chains at C-20, Gemini-0072 and Gemini-0097.",Danio rerio,2.5001
3P8X,"Synthesis, Structure, and Biological Activity of des-Side Chain Analogues of 1alpha,25-Dihydroxyvitamin D3 with Substituents at C-18",Homo sapiens,1.7
3VHW,Crystal structure of the human vitamin D receptor ligand binding domain complexed with 4-MP,Homo sapiens,2.43
3W0A,Crystal Structure Analysis of Vitamin D receptor,Homo sapiens,1.8
3W0C,Crystal Structure Analysis of Vitamin D receptor,Homo sapiens,1.9
3W0Y,Crystal Structure Analysis of Vitamin D receptor,Homo sapiens,1.98
3WWR,"Crystal structure of the human vitamin D receptor ligand binding domain complexed with 1-((((1S,2R,6R,Z)-2,6-dihydroxy-4-((E)-2-((1R,3aS,7aR)-1-((R)-6-hydroxy-6-methylheptan-2-yl)-7a-methylhexahydro-1H-inden-4(2H)-ylidene)ethylidene)-3-methylenecyclohexyl)oxy)methyl)cyclopropanecarbonitrile",Homo sapiens,3.18
3X31,"Crystal structure of the human vitamin D receptor ligand binding domain complexed with 7,8-cis-14-epi-1a,25-Dihydroxy-19-norvitamin D3",Homo sapiens,2.11
3X36,"Crystal structure of the human vitamin D receptor ligand binding domain complexed with 7,8-cis-1a,25-Dihydroxy-19-norvitamin D3",Homo sapiens,1.93
4FHH,Development of synthetically accessible non-secosteroidal hybrid molecules combining vitamin D receptor agonism and histone deacetylase inhibition,Danio rerio,2.33
4ITE,"Crystal structure of the human vitamin D receptor ligand binding domain complexed with 1alpha,25-Dihydroxy-2alpha-[2-(2H-tetrazol-2-yl)ethyl]vitamin D3",Homo sapiens,2.49
4ITF,"Crystal structure of the human vitamin D receptor ligand binding domain complexed with 1alpha,25-Dihydroxy-2alpha-[2-(1H-tetrazole-1-yl)ethyl]vitamin D3",Homo sapiens,2.84
4Q0A,Vitamin D Receptor complex with lithocholic acid,Danio rerio,1.9
4RUO,Crystal structure of zVDR L337H mutant-gemini complex,Danio rerio,2.805
5LGA,"Structural analysis and biological activities of BXL0124, a Gemini analog of Vitamin D",Danio rerio,2.5
8P9X,Vitamin D receptor complex with Xe4Me agonist ligand,Danio rerio,2.15
7QPI,"Structure of lamprey VDR in complex with 1,25D3",Petromyzon marinus,2.5
7OXU,VDR complex - calcitroic acid,Danio rerio,2.39
4G1D,Structural basis for the accommodation of bis- and tris-aromatic derivatives in Vitamin D Nuclear Receptor,Danio rerio,2.9
4G1Y,Structural basis for the accommodation of bis- and tris-aromatic derivatives in Vitamin D Nuclear Receptor,Danio rerio,2.85
4G1Z,Structural basis for the accommodation of bis- and tris-aromatic derivatives in Vitamin D Nuclear Receptor,Danio rerio,2.5
4G20,Structural basis for the accommodation of bis- and tris-aromatic derivatives in Vitamin D Nuclear Receptor,Danio rerio,2.9
4G21,Structural basis for the accommodation of bis- and tris-aromatic derivatives in Vitamin D Nuclear Receptor,Danio rerio,2.9
4G2H,Structural basis for the accommodation of bis- and tris-aromatic derivatives in Vitamin D Nuclear Receptor,Danio rerio,2.5
5E7V,Potent Vitamin D Receptor Agonist,Danio rerio,2.4
5MX7,"1a,20S-dihydroxyvitamin D3 VDR complex",Danio rerio,1.98
5OW7,VDR complex,Danio rerio,2.1
7BNS,VDR complex with BXL-62,Danio rerio,2.7
7BNU,VDR complex with BXL-62,Danio rerio,2.4
7BO6,VDR complex with LCA derivative,Danio rerio,2.86
7ZFG,VDR complex with aromatic D-ring analog,Danio rerio,2.62
7ZFX,VDR complex with Aromatic-D-Ring Analog,Danio rerio,2.6
8CK5,"VDR LBD complex with 25-nitro derivative of 1,25D3",Danio rerio,2.1
9EYR,VDR complex with gemini analog UG-480,Danio rerio,2.56
9FBF,VDR complex with UG-481,Danio rerio,3.01
2ZL9,"2-Substituted-16-ene-22-thia-1alpha,25-dihydroxy-26,27-dimethyl-19-norvitamin D3 analogs: Synthesis, biological evaluation and crystal structure",Rattus norvegicus,1.9
2ZLA,"2-Substituted-16-ene-22-thia-1alpha,25-dihydroxy-26,27-dimethyl-19-norvitamin D3 analogs: Synthesis, biological evaluation and crystal structure",Rattus norvegicus,2.0
2ZLC,"2-Substituted-16-ene-22-thia-1alpha,25-dihydroxy-26,27-dimethyl-19-norvitamin D3 analogs: Synthesis, biological evaluation and crystal structure",Rattus norvegicus,2.0
3VT4,Crystal structures of rat VDR-LBD with R270L mutation,Rattus norvegicus,1.9
3VT5,Crystal structures of rat VDR-LBD with R270L mutation,Rattus norvegicus,2.11
3VT6,"Crystal structure of rat VDR-LBD with 2-Substituted-16-ene-22-thia-1alpha,25-dihydroxy-26,27-dimethyl-19-norvitamin D3",Rattus norvegicus,2.3
3VT8,Crystal structures of rat VDR-LBD with W282R mutation,Rattus norvegicus,2.1
3VT9,Crystal structures of rat VDR-LBD with W282R mutation,Rattus norvegicus,2.35
3A40,Crystal structure of the human VDR ligand binding domain bound to the synthetic agonist compound 2alpha-methyl-AMCR277B(C23R),Homo sapiens,1.45
3KPZ,"Crystal structure of a novel vitamin D3 analogue, ZK203278 showing dissociated profile",Homo sapiens,1.9
3OGT,"Design, Chemical synthesis, Functional characterization and Crystal structure of the sidechain analogue of 1,25-dihydroxyvitamin D3.",Homo sapiens,1.75
3TKC,"Design, Synthesis, Evaluation and Structure of Vitamin D Analogues with Furan Side Chains",Homo sapiens,1.75
3WGP,Crystal Structure Analysis of Vitamin D receptor,Homo sapiens,2.0
3AFR,"Crystal Structure of VDR-LBD/22S-Butyl-1a,24R-dihydroxyvitamin D3 complex",Rattus norvegicus,2.0
3VT3,Crystal structures of rat VDR-LBD with R270L mutation,Rattus norvegicus,1.7
1IE8,Crystal Structure Of The Nuclear Receptor For Vitamin D Ligand Binding Domain Bound to KH1060,Homo sapiens,1.52
1IE9,Crystal Structure Of The Nuclear Receptor For Vitamin D Ligand Binding Domain Bound to MC1288,Homo sapiens,1.4
3A3Z,Crystal structure of the human VDR ligand binding domain bound to the synthetic agonist compound 2alpha-methyl-AMCR277A(C23S),Homo sapiens,1.72
3A78,"Crystal structure of the human VDR ligand binding domain bound to the natural metabolite 1alpha,25-dihydroxy-3-epi-vitamin D3",Homo sapiens,1.9
3DR1,Side-chain fluorine atoms of non-steroidal vitamin D3 analogs stabilize helix 12 of vitamin D receptor,Danio rerio,2.7
4RUJ,Crystal structure of zVDR L337H mutant-VD complex,Danio rerio,2.352
4RUP,Crystal structure of zVDR L337H mutant-Gemini72 complex,Danio rerio,2.75
5NKY,Structure-activity relationship study of vitamin D analogs with oxolane group in their side chain,Danio rerio,2.096
5NMA,Structure-activity relationship study of vitamin D analogs with oxolane group in their side chain,Danio rerio,2.8
5NMB,Structure-activity relationship study of vitamin D analogs with oxolane group in their side chain,Danio rerio,2.5
5OW9,Vitamin D receptor complex,Danio rerio,2.403
5OWD,Vitamin D receptor complex,Danio rerio,2.151
6FO7,Vitamin D nuclear receptor complex 3,Danio rerio,2.59
6FO8,Vitamin D nuclear receptor complex 4,Danio rerio,2.3
6FO9,Vitamin D nuclear receptor complex 2,Danio rerio,2.701
6FOB,Vitamin D receptor complex 5,Danio rerio,2.75
6FOD,Vitamin D nuclear receptor complex 1,Danio rerio,2.5
7B39,Allene-Based Design of a Noncalcemic Vitamin D Receptor Agonist,Danio rerio,2.13
8CKC,"Vitamin D receptor complex with 25-amine derivative of 1,25D3",Danio rerio,2.1
8P9W,vitamin D receptor complex with Xe4MeCF3 analog,Danio rerio,2.9
5XPM,"Crystal structure of VDR-LBD complexed with 22S-Butyl-25RS-(hydroxyphenyl)-25-methoxy-2-methylidene-19,26,27-trinor-1-hydroxyvitamin D3",Rattus norvegicus,2.2
5XPN,"Crystal structure of VDR-LBD complexed with 25RS-(hydroxyphenyl)-25-methoxy-2-methylidene-19,26,27-trinor-1-hydroxyvitamin D3",Rattus norvegicus,1.96
5XPO,"Crystal structure of VDR-LBD complexed with 25-(hydroxyphenyl)-2-methylidene-19,26,27-trinor-25-oxo-1-hydroxyvitamin D3",Rattus norvegicus,2.28
5XPP,"Crystal structure of VDR-LBD complexed with 25RS-(Hydroxyphenyl)-2-methylidene-19,26,27-trinor-1,25-dihydroxyvitamin D3",Rattus norvegicus,2.85
5H1E,Interaction between vitamin D receptor and coactivator peptide SRC2-3,Rattus norvegicus,2.6
3VTB,Crystal structure of rat vitamin D receptor bound to a partial agonist 25-adamantyl-23-yne-19-norvitammin D ADTK1,Rattus norvegicus,2.0
3VTC,Crystal structure of rat vitamin D receptor bound to a partial agonist 26-adamantyl-23-yne-19-norvitammin D ADTK3,Rattus norvegicus,1.5
3VTD,Crystal structure of rat vitamin D receptor bound to a partial agonist 26-adamantyl-23-yne-19-norvitammin D ADTK4,Rattus norvegicus,2.7
2ZMH,Crystal Structure of Rat Vitamin D Receptor Bound to Adamantyl Vitamin D Analogs: Structural Basis for Vitamin D Receptor Antagonism and/or Partial Agonism,Rattus norvegicus,2.1
2ZMJ,Crystal Structure of Rat Vitamin D Receptor Bound to Adamantyl Vitamin D Analogs: Structural Basis for Vitamin D Receptor Antagonism and/or Partial Agonism,Rattus norvegicus,2.35
2ZXM,A New Class of Vitamin D Receptor Ligands that Induce Structural Rearrangement of the Ligand-binding Pocket,Rattus norvegicus,3.01
2ZXN,A New Class of Vitamin D Receptor Ligands that Induce Structural Rearrangement of the Ligand-binding Pocket,Rattus norvegicus,2.1
3WTQ,"Crystal structure of VDR-LBD complexed with 22S-butyl-2-methylidene-19-nor-1a,25-dihydroxyvitamin D3",Rattus norvegicus,2.1
5B41,"Crystal structure of VDR-LBD complexed with 2-methylidene-19-nor-1a,25-dihydroxyvitamin D3",Rattus norvegicus,1.89
5B5B,"Crystal structure of VDR-LBD complexed with 2-methylidene-26,27-diphenyl-19-nor-1,25-dihydroxyvitamin D3",Rattus norvegicus,2.0
5GIC,Crystal structure of VDR in complex with DLAM-2P,Rattus norvegicus,2.352
5GID,Crystal structure of VDR in complex with DLAM-4 (C2 form),Rattus norvegicus,2.151
5GIE,Crystal structure of VDR in complex with DLAM-4P (P21 form),Rattus norvegicus,2.387
5XUQ,"Crystal structure of VDR-LBD complexed with an antagonist, 2-methylidene-19,26,27-trinor-22-(S)-butyl-1-hydroxy-25-oxo-25-(1H-pyrrol-2-yl)- vitamin D3",Rattus norvegicus,2.8
2ZMI,Crystal Structure of Rat Vitamin D Receptor Bound to Adamantyl Vitamin D Analogs: Structural Basis for Vitamin D Receptor Antagonism and/or Partial Agonism,Rattus norvegicus,1.7
2HC4,Crystal structure of the LBD of VDR of Danio rerio in complex with calcitriol,Danio rerio,2.2
1DB1,CRYSTAL STRUCTURE OF THE NUCLEAR RECEPTOR FOR VITAMIN D COMPLEXED TO VITAMIN D,Homo sapiens,1.8
4FHI,Development of synthetically accessible non-secosteroidal hybrid molecules combining vitamin D receptor agonism and histone deacetylase inhibition,Danio rerio,2.4
2O4J,Crystal Structure of Rat Vitamin D Receptor Ligand Binding Domain Complexed with VitIII 17-20Z and the NR2 Box of DRIP 205,Rattus norvegicus,1.74
2O4R,Crystal Structure of Rat Vitamin D Receptor Ligand Binding Domain Complexed with VitIII 17-20E and the NR2 Box of DRIP 205,Rattus norvegicus,1.98
4YNK,Crystal structure of vitamin D receptor ligand binding domain complexed with a 19-norvitamin D compound,Rattus norvegicus,2.3
5AWJ,Crystal structure of VDR-LBD/partial agonist complex: 22S-hexyl analogue,Rattus norvegicus,2.2
5AWK,Crystal structure of VDR-LBD/partial agonist complex: 22S-ethyl analogue,Rattus norvegicus,2.9
5ZWE,Covalent bond formation between histidine of Vitamin D receptor (VDR) and a full agonist having a vinyl ketone group via conjugate addition reaction,Rattus norvegicus,2.72
5ZWF,Covalent bond formation between histidine of Vitamin D receptor (VDR) and a full agonist having a enone with a beta methyl group via conjugate addition reaction,Rattus norvegicus,2.1
5ZWH,Covalent bond formation between histidine of Vitamin D receptor (VDR) and a full agonist having an ene-ynone group via conjugate addition reaction,Rattus norvegicus,2.38
5ZWI,Interaction between Vitamin D receptor (VDR) and a ligand having a dienone group,Rattus norvegicus,2.4
6JEZ,Covalent labeling of rVDR-LBD by turn-on fluorescent probe mediated by conjugate addition and cyclization,Rattus norvegicus,2.3
2ZFX,Crystal structure of the rat vitamin D receptor ligand binding domain complexed with YR301 and a synthetic peptide containing the NR2 box of DRIP 205,Rattus norvegicus,1.99
3A2H,Crystal structure of the rat vitamin D receptor ligand binding domain complexed with TEI-9647 and a synthetic peptide containing the NR2 box of DRIP 205,Rattus norvegicus,2.5
3VRT,"VDR ligand binding domain in complex with 2-Mehylidene-19,25,26,27-tetranor-1alpha,24-dihydroxyvitaminD3",Rattus norvegicus,2.4
3VRU,"VDR ligand binding domain in complex with 2-Methylidene-19,24-dinor-1alpha,25-dihydroxy vitaminD3",Rattus norvegicus,2.0
3VRV,"VDR ligand binding domain in complex with 2-Methylidene-26,27-dimethyl-19,24-dinor-1alpha,25-dihydroxyvitamin D3",Rattus norvegicus,1.9
3VRW,"VDR ligand binding domain in complex with 22S-Butyl-2-methylidene-26,27-dimethyl-19,24-dinor-1alpha,25-dihydroxyvitamin D3",Rattus norvegicus,2.4
3VT7,Crystal structures of rat VDR-LBD with W282R mutation,Rattus norvegicus,1.65
3W0G,Crystal Structure of Rat VDR Ligand Binding Domain in Complex with Novel Nonsecosteroidal Ligands,Rattus norvegicus,1.94
3W0H,Crystal Structure of Rat VDR Ligand Binding Domain in Complex with Novel Nonsecosteroidal Ligands,Rattus norvegicus,1.8
3W0I,Crystal Structure of Rat VDR Ligand Binding Domain in Complex with Novel Nonsecosteroidal Ligands,Rattus norvegicus,1.9
3W0J,Crystal Structure of Rat VDR Ligand Binding Domain in Complex with Novel Nonsecosteroidal Ligands,Rattus norvegicus,1.84
3WT7,"Crystal structure of VDR-LBD complexed with 22R-Butyl-2-methylidene-26,27-dimethyl-19,24-dinor-1 ,25-dihydroxyvitamin D3",Rattus norvegicus,2.4
5XZF,Vitamin D receptor with a synthetic ligand ADRO1,Rattus norvegicus,2.1
5XZH,Vitamin D receptor with a synthetic ligand ADRO2,Rattus norvegicus,2.0
6K5O,Development of Novel Lithocholic Acid Derivatives as Vitamin D Receptor Agonists,Rattus norvegicus,1.8
7C7V,Vitamin D3 receptor/lithochoric acid derivative complex,Rattus norvegicus,2.0
7C7W,Vitamin D3 receptor/lithochoric acid derivative complex,Rattus norvegicus,1.9
2HBH,Crystal structure of Vitamin D nuclear receptor ligand binding domain bound to a locked side-chain analog of calcitriol and SRC-1 peptide,Danio rerio,2.65
2HCD,Crystal structure of the ligand binding domain of the Vitamin D nuclear receptor in complex with Gemini and a coactivator peptide,Danio rerio,2.6
1RJK,crystal structure of the rat vitamin D receptor ligand binding domain complexed with 2MD and a synthetic peptide containing the NR2 box of DRIP 205,Rattus norvegicus,1.99
1RK3,"crystal structure of the rat vitamin D receptor ligand binding domain complexed with 1,25-dihydroxyvitamin D3 and a synthetic peptide containing the NR2 box of DRIP 205",Rattus norvegicus,2.2
1RKG,crystal structure of the rat vitamin D receptor ligand binding domain complexed with 2MbisP and a synthetic peptide containing the NR2 box of DRIP 205,Rattus norvegicus,1.9
1RKH,crystal structure of the rat vitamin D receptor ligand binding domain complexed with 2AM20R and a synthetic peptide containing the NR2 box of DRIP 205,Rattus norvegicus,2.28
3VJS,Vitamin D receptor complex with a carborane compound,Rattus norvegicus,1.93
3VJT,Vitamin D receptor complex with a carborane compound,Rattus norvegicus,2.0
3W5P,Crystal structure of complexes of vitamin D receptor ligand binding domain with lithocholic acid derivatives,Rattus norvegicus,1.9
3W5Q,Crystal structure of complexes of vitamin D receptor ligand binding domain with lithocholic acid derivatives,Rattus norvegicus,1.9
3W5R,Crystal structure of complexes of vitamin D receptor ligand binding domain with lithocholic acid derivatives,Rattus norvegicus,2.2
3W5T,Crystal structure of complexes of vitamin D receptor ligand binding domain with lithocholic acid derivatives,Rattus norvegicus,2.29
3WT5,A mixed population of antagonist and agonist binding conformers in a single crystal explains partial agonism against vitamin D receptor: Active vitamin D analogues with 22R-alkyl group,Rattus norvegicus,1.9
3WT6,A mixed population of antagonist and agonist binding conformers in a single crystal explains partial agonism against vitamin D receptor: Active vitamin D analogues with 22R-alkyl group,Rattus norvegicus,2.0
3AUN,Crystal structure of the rat vitamin D receptor ligand binding domain complexed with YR335 and a synthetic peptide containing the NR2 box of DRIP 205,Rattus norvegicus,1.81
7VQP,Vitamin D receptor complexed with a lithocholic acid derivative,Rattus norvegicus,1.94
